| Line Item | 2024-12-28 | Y/Y |
|---|---|---|
| Revenue | $6.30B | +20.4% |
| Cost of Revenue | $2.60B | +17.0% |
| Gross Profit | $3.70B | +23.0% |
| R&D Expense | $993.6M | +9.8% |
| SG&A Expense | $1.11B | +32.8% |
| Operating Income | $1.59B | +45.9% |
| Pre-tax Income | $1.70B | +41.2% |
| Income Tax | $284.0M | +418.1% |
| Net Income | $1.41B |
| Line Item | 2024-12-28 | Y/Y |
|---|---|---|
| Cash & Equivalents | $2.08B | +22.8% |
| Accounts Receivable | $983.4M | +20.6% |
| Inventory | $1.47B | +9.5% |
| Current Assets | $5.34B | +19.5% |
| Total Assets | $9.63B | +11.9% |
| Current Liabilities | $1.51B | +15.0% |
| Stockholders' Equity | $7.85B | +11.9% |
| Line Item | 2024-12-28 | Y/Y |
|---|---|---|
| Operating Cash Flow | $1.43B | +4.1% |
| Capital Expenditures | $193.6M | +0.0% |
| Investing Cash Flow | -$393.3M | -18.1% |
| Financing Cash Flow | -$626.9M | +1.5% |
| Free Cash Flow | $1.24B | +4.7% |
| +9.4% |
| EPS (Basic) | $7.35 | +9.1% |
| EPS (Diluted) | $7.30 | +8.8% |